Arcellx Inc (ACLX): Next-Year EPS Estimate 59.11%
As of 2026-05-07, Arcellx Inc (ACLX) has a next-year EPS growth estimate of 59.11%.
On 2026-05-03, analyst consensus for ACLX's next-year EPS growth shifted from 57.88% to 59.11% — a positive change of 1.23 percentage points. The revised estimate has been sustained across 5 subsequent trading sessions. Current-year growth is projected at 15.45%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 59.11%
- EPS growth this year
- 15.45%
- EPS next quarter (est)
- -$1.07
- Last price
- $115.07
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-07 | 59.11% | 15.45% | -$1.07 | $115.07 |
| 2026-05-06 | 59.11% | 15.45% | -$1.07 | $115.07 |
| 2026-05-05 | 59.11% | 15.45% | -$1.07 | $115.07 |
| 2026-05-04 | 59.11% | 15.45% | -$1.07 | $115.07 |
| 2026-05-03 | 59.11% | 15.45% | -$1.07 | $115.07 |
| 2026-04-30 | 57.88% | 12.49% | -$1.07 | $115.07 |
| 2026-04-29 | 51.80% | 13.07% | -$1.07 | $115.07 |
| 2026-04-28 | 51.21% | 10.47% | -$1.10 | $115.07 |
| 2026-04-27 | 51.55% | 9.84% | -$1.11 | $115.07 |
| 2026-04-26 | 53.49% | 9.84% | -$1.11 | $115.03 |
| 2026-04-24 | 53.49% | 9.84% | -$1.11 | $115.03 |
| 2026-04-23 | 53.49% | 9.84% | -$1.11 | $115.05 |
| 2026-04-22 | 53.49% | 9.84% | -$1.11 | $115.00 |
| 2026-04-21 | 53.49% | 9.84% | -$1.11 | $114.98 |
| 2026-04-20 | 53.49% | 9.84% | -$1.11 | $115.00 |
| 2026-04-19 | 53.49% | 9.84% | -$1.11 | $115.05 |
| 2026-04-16 | 53.49% | 9.84% | -$1.11 | $115.10 |
| 2026-04-15 | 53.49% | 9.84% | -$1.11 | $115.00 |
| 2026-04-14 | 53.49% | 9.84% | -$1.11 | $114.89 |
| 2026-04-13 | 53.49% | 9.84% | -$1.11 | $114.87 |
| 2026-04-12 | 53.49% | 9.84% | -$1.11 | $114.83 |
| 2026-04-10 | 53.49% | 9.84% | -$1.11 | $114.81 |
| 2026-04-09 | 53.49% | 9.84% | -$1.11 | $114.80 |
| 2026-04-08 | 53.49% | N/A | -$1.11 | $114.79 |
| 2026-04-07 | 53.49% | N/A | -$1.11 | $114.80 |
| 2026-04-06 | 53.49% | N/A | -$1.11 | $114.80 |
| 2026-04-05 | 53.49% | N/A | -$1.11 | $114.77 |
| 2026-04-03 | 53.49% | N/A | -$1.11 | $114.80 |
| 2026-04-02 | 53.49% | N/A | -$1.11 | $114.80 |
| 2026-04-01 | 53.49% | N/A | -$1.11 | $114.80 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Arcellx Inc's next-year EPS growth estimate?▾
As of 2026-05-07, Arcellx Inc (ACLX) has a next-year EPS growth estimate of 59.11%, based on analyst consensus.
When was the latest EPS estimate revision for ACLX?▾
The most recent revision occurred on 2026-05-03, when analysts adjusted the next-year EPS growth estimate from 57.88% to 59.11%.
What sector and industry does Arcellx Inc belong to?▾
Arcellx Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ACLX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Arcellx Inc (ACLX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports